Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets, CFDs, OTC options or any of our other products work and whether you can afford to take the high risk of losing your money.

69% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.

5 Top Stories

The Bletchley Declaration; Ørsted Drops US Projects; Pharma’s Mixed Fortunes

Every day, we handpick the 5 Top Stories stock market investors need to know. In 5 minutes, you’ll learn the stocks, CEOs, and money managers moving markets.

The Bletchley Declaration

Wednesday saw a host of influential people — among them Elon Musk, US Vice President Kamala Harris and European Commission President Ursula von der Leyen — descend on Bletchley Park near London for Prime Minister Rishi Sunak’s two-day artificial intelligence (AI) safety summit. That morning the UK government released ‘The Bletchley Declaration’, a document signed by representatives from the 28 countries attending the event, committing to “inclusive global dialogue”.

Ørsted Drops US Projects; Neste to Shed Jobs

Denmark’s Ørsted [ORSTED.CO], the world’s largest offshore wind developer, has said it had “no choice” but to drop two major US-based projects off the New Jersey coast. The firm also announced $4bn of impairments, beyond expectations. Its stock price fell 15% Wednesday on the news. Meanwhile, Finland's Neste [NESTE.HE], the world's largest producer of renewable diesel, plans to save $53m annually through lay-offs as it prepares for an intensification of competition in renewable fuels.

Pharma’s Mixed Fortunes

Moderna [MRNA] expects to meet the lower end of its 2023 sales target for Covid-19 vaccines, with at least $2bn in commercial sales. Pfizer [PFE] announced last month that it lowered its outlook for its Covid-19 vaccines this year due to lower-than-expected vaccination rates. GSK [GSK] raised its 2023 profit forecast following the strong launch of its respiratory syncytial virus (RSV) vaccine. GSK has supplied two-thirds of the RSV doses administered in the US since early September.

Toyota Injects $8bn into Battery Plant

Toyota [TM] will invest an additional $8bn in a battery plant under construction in North Carolina, bringing the total investment to $13.9bn. It will be the company’s first in North America and powered entirely by renewable energy. On Wednesday the company raised its profit forecast by 50%. Elon Musk announced Tesla [TSLA] will make 200,000 Cybertrucks a year, with deliveries commencing 30 November. A Chinese court cleared the company of fault in a 2022 accident that killed two and injured three.

Southeast Asian E-commerce Players Grapple Slowdown

Total online spending in southeast Asia is set to grow by 11% this year to $218bn, Bloomberg reported, the slowest expansion on record. Global giants like Amazon [AMZN] and Alibaba [9988.HK] are competing with local players Grab Holdings [A6I.SG], Sea [SE] and GoTo Group [GOTO.JK] for market share. The region’s internet economy is set to reach $295bn by 2025, down from a previous estimate of $330bn.

Disclaimer Past performance is not a reliable indicator of future results.

CMC Markets is an execution-only service provider. The material (whether or not it states any opinions) is for general information purposes only, and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person.

The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although we are not specifically prevented from dealing before providing this material, we do not seek to take advantage of the material prior to its dissemination.

CMC Markets does not endorse or offer opinion on the trading strategies used by the author. Their trading strategies do not guarantee any return and CMC Markets shall not be held responsible for any loss that you may incur, either directly or indirectly, arising from any investment based on any information contained herein.

*Tax treatment depends on individual circumstances and can change or may differ in a jurisdiction other than the UK.

Continue reading for FREE

Latest articles